Transcriptome ‐ wide association study of breast cancer risk by estrogen ‐ receptor status
暂无分享,去创建一个
Jack A. Taylor | W. Chung | S. Cross | M. Beckmann | P. Fasching | C. Weinberg | C. Vachon | K. Czene | P. Hall | K. Humphreys | F. Couch | H. Brenner | J. Chang-Claude | S. Chanock | M. García-Closas | B. Bonanni | R. Hoover | O. Olopade | B. Karlan | J. Benítez | G. Giles | J. Hopper | C. Haiman | E. John | A. Spurdle | T. Dörk | M. Southey | A. Cox | D. Easton | P. Kraft | G. Rennert | R. Scott | A. Hollestelle | J. Martens | A. Broeks | D. Lambrechts | J. Peto | E. Khusnutdinova | M. Greene | K. Offit | A. Antoniou | J. Spinelli | Å. Borg | H. Brauch | V. Kristensen | J. Long | X. Shu | W. Zheng | A. Ziogas | H. Anton-Culver | P. Guénel | U. Menon | R. Barkardottir | A. Dunning | D. Eccles | O. Fletcher | N. Johnson | G. Chenevix-Trench | S. Bojesen | H. Nevanlinna | N. Bogdanova | R. Tollenaar | P. Devilee | R. Milne | A. González-Neira | U. Hamann | A. Mannermaa | C. Lázaro | K. Nathanson | S. Lindström | C. Clarke | J. Garber | C. Isaacs | K. Michailidou | J. Dennis | M. Schmidt | M. Bolla | Qin Wang | T. Muranen | K. Aittomäki | C. Blomqvist | A. Meindl | R. Schmutzler | E. Makalic | D. Schmidt | S. Canisius | H. Flyger | T. Truong | B. Burwinkel | E. Sawyer | I. Andrulis | G. Glendon | A. Mulligan | S. Margolin | M. Hooning | J. Stone | V. Arndt | A. Swerdlow | M. Goldberg | R. Winqvist | K. Pylkäs | T. Brüning | P. Radice | P. Peterlongo | S. Manoukian | A. Jakubowska | J. Lubiński | A. Toland | F. Fostira | Q. Cai | J. Simard | P. Pharoah | M. Eriksson | M. Schoemaker | S. Neuhausen | C. V. van Asperen | M. Bermisheva | H. Christiansen | T. Park-Simon | D. Torres | A. V. D. van den Ouweland | M. Robson | M. Dwek | W. Tapper | D. Yannoukakos | L. McGuffog | A. Godwin | D. Campa | E. Friedman | S. Gapstur | N. Tung | E. Imyanitov | P. Ganz | A. Osorio | P. Hulick | A. Gusev | B. Wappenschmidt | P. Auer | J. Taylor | S. Domchek | B. Pasaniuc | N. Lindor | H. Risch | A. Viel | D. Frost | F. Hogervorst | C. Engel | C. Singer | K. Claes | J. Rantala | B. Arun | K. Aronson | A. Arason | I. Campbell | O. Díez | M. U. Rashid | Austin Miller | B. Poppe | D. Plaseska-Karanfilska | F. Nielsen | P. James | M. Daly | A. Jung | M. Manoochehri | Camilla Wendt | K. Punie | D. Goldgar | D. Barnes | M. Thomassen | J. García-Saenz | F. Moreno | B. Ejlertsen | B. Boeckx | D. Sandler | L. Nikitina-Zake | J. Lester | C. Cybulski | M. Teixeira | I. Nevelsteen | L. Fritschi | J. Balmaña | J. Weitzel | M. Tischkowitz | M. Terry | J. Heyworth | J. Gronwald | M. Martínez | J. Castelao | F. Lesueur | Wei He | H. Olsson | M. Gabrielson | M. Gaudet | E. Oláh | P. Soucy | D. Barrowdale | M. Montagna | T. Caldés | E. J. van Rensburg | M. Caligo | R. Janavicius | D. Leroux | Y. Laitman | A. Skytte | I. Pedersen | Á. Teulé | J. Loud | A. Romero | M. de la Hoya | S. Behrens | B. Carter | Carolina Ellberg | Guanmengqian Huang | M. Jakimovska | W. Lo | D. Mavroudis | N. Presneau | E. Saloustros | K. Thöne | Xiaohong R. Yang | A. Vega | K. Phillips | Xia Jiang | P. Sharma | J. Azzollini | K. Białkowska | I. Briceño | R. Jankowitz | P. Kapoor | I. Konstantopoulou | T. Maurer | J. Papp | M. Parsons | K. Prajzendanc | D. Thull | V. Joseph | K. De Leeneer | A. Peixoto | Lang Wu | Helian Feng | L. Moserle | Nisha Pradhan | Catarina Santos | A. Blanco | E. Asseryanis | Paula Vieiro-Balo | J. E. Castelao | Goska Leslie | L. Matricardi | Christopher R. Hake | J. Kiiski | I. dos-Santos-Silva | Priyanka Sharma | Zomoroda Abu-full | J. Carter | Ou Shu | A. Teule | J. Stone | Thérèse Truong | P. Hall | Kelly | A. Phillips | Xiao | R. Scott | Ana Peixoto
[1] Hebon Investigators,et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status , 2020 .
[2] Michael Wainberg,et al. Opportunities and challenges for transcriptome-wide association studies , 2019, Nature Genetics.
[3] A. Gusev,et al. Probabilistic fine-mapping of transcriptome-wide association studies , 2017, Nature Genetics.
[4] Jane E. Carpenter,et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer , 2019, Nature Communications.
[5] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[6] Jeffery M. Meyer,et al. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer , 2018, Nature Genetics.
[7] Peter Kraft,et al. Transcriptome‐wide association studies accounting for colocalization using Egger regression , 2018, Genetic epidemiology.
[8] Michael Jones,et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer , 2017, Nature Genetics.
[9] Gary D Bader,et al. Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.
[10] O. Olopade,et al. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer , 2017, PLoS genetics.
[11] Alexander Gusev,et al. Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits. , 2017, American journal of human genetics.
[12] J. Witte,et al. Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk , 2017, PLoS genetics.
[13] Dennis J. Hazelett,et al. The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[14] S. Cross,et al. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) , 2016, Scientific Reports.
[15] Nicholas A. Sinnott-Armstrong,et al. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 , 2016, Nature Genetics.
[16] T. Lehtimäki,et al. Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.
[17] Wei Zheng,et al. Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 , 2016 .
[18] Kaanan P. Shah,et al. A gene-based association method for mapping traits using reference transcriptome data , 2015, Nature Genetics.
[19] G. Kempermann. Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .
[20] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[21] Jane E. Carpenter,et al. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.
[22] Patrick Neven,et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer , 2015 .
[23] S. Cross,et al. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk , 2022 .
[24] D. Noh,et al. Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1 , 2014, Nature Genetics.
[25] F. Verbeek,et al. Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation , 2014, Oncogene.
[26] Gaurav Bhatia,et al. Fast and accurate imputation of summary statistics enhances evidence of functional enrichment , 2013, Bioinform..
[27] Halverson,et al. Identification and characterization of novel associations in the CASP 8 / ALS 2 CR 12 region on chromosome 2 with breast cancer risk , 2014 .
[28] R. Young,et al. Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.
[29] T. Dörk,et al. Hereditary breast cancer: ever more pieces to the polygenic puzzle , 2013, Hereditary Cancer in Clinical Practice.
[30] F. Bertolini. Adipose tissue and breast cancer progression: a link between metabolism and cancer. , 2013, Breast.
[31] B. Klein,et al. The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk , 2013, Breast Cancer Research and Treatment.
[32] Patrick Neven,et al. Genome-wide association studies identify four ER negative–specific breast cancer risk loci , 2013, Nature Genetics.
[33] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[34] D. Easton,et al. Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations , 2012, Genetic epidemiology.
[35] O. Delaneau,et al. A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.
[36] Victoria L. Cafourek,et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.
[37] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[38] Mads Thomassen,et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. , 2010, Cancer research.
[39] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[40] P. Visscher,et al. Common SNPs explain a large proportion of heritability for human height , 2011 .
[41] Deborah Hughes,et al. Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.
[42] Montserrat Garcia-Closas,et al. Genetic susceptibility to breast cancer , 2010, Molecular oncology.
[43] Päivi Heikkilä,et al. Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.
[44] N. Cox,et al. Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS , 2010, PLoS genetics.
[45] S. Hodgson,et al. Genomics and breast cancer: the different levels of inherited susceptibility , 2009, European Journal of Human Genetics.
[46] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[47] R. Eils,et al. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms , 2009, Breast Cancer Research and Treatment.
[48] Christopher I Amos,et al. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] Matthias O. Franz,et al. Plant Classification from Bat-Like Echolocation Signals , 2008, PLoS Comput. Biol..
[50] K. Taylor,et al. Genome-Wide Association , 2007, Diabetes.
[51] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[52] Jaana M. Hartikainen,et al. A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.
[53] R. Lyngsoe G. Hellenthal,et al. Genome-wide association analysis , 2007 .
[54] Nazneen Rahman,et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles , 2006, Nature Genetics.
[55] J. Chang-Claude,et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes , 2005, Genetic epidemiology.